Bilateral hearing loss during vincristine therapy: A case report
dc.authorid | KAYA, Emin/0000-0001-8605-8497; | |
dc.authorwosid | KAYA, Emin/W-2951-2017 | |
dc.authorwosid | KALCIOGLU, Mahmut Tayyar/I-5884-2013 | |
dc.authorwosid | Kalcioglu, M. Tayyar/JAC-1515-2023 | |
dc.contributor.author | Kalcioglu, MT | |
dc.contributor.author | Kuku, I | |
dc.contributor.author | Kaya, E | |
dc.contributor.author | Oncel, S | |
dc.contributor.author | Aydogdu, I | |
dc.date.accessioned | 2024-08-04T20:13:20Z | |
dc.date.available | 2024-08-04T20:13:20Z | |
dc.date.issued | 2003 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Vincristine sulfate is a chemotherapeutic agent used in different cancer therapies. It is also the first choice of treatment for peripheral T-cell lymphoma with cyclophosphamide and adriamycin. Sudden hearing loss during vincristine therapy is a very rare event. This is a case of a 16-year old girl who developed sudden bilateral hearing loss related to vincristine therapy. | en_US |
dc.identifier.doi | 10.1179/joc.2003.15.3.290 | |
dc.identifier.endpage | 292 | en_US |
dc.identifier.issn | 1120-009X | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 12868558 | en_US |
dc.identifier.scopus | 2-s2.0-0038345540 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 290 | en_US |
dc.identifier.uri | https://doi.org/10.1179/joc.2003.15.3.290 | |
dc.identifier.uri | https://hdl.handle.net/11616/93553 | |
dc.identifier.volume | 15 | en_US |
dc.identifier.wos | WOS:000184062100014 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | E I F T Srl | en_US |
dc.relation.ispartof | Journal of Chemotherapy | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | vincristine | en_US |
dc.subject | hearing loss | en_US |
dc.subject | toxicity | en_US |
dc.subject | peripheral T-cell lymphoma | en_US |
dc.title | Bilateral hearing loss during vincristine therapy: A case report | en_US |
dc.type | Article | en_US |